Abstract
Tools and techniques leading to drug discovery from natural compounds are of immense interest. Studies related to the identification and isolation of bioactive phytochemicals and their associated therapeutic potential are routinely adopted for the discovery and development of new drug molecules against various diseases. In this chapter, we discussed the latest tools and techniques that can be adopted to exploit the potential of bioactive phytochemicals from Medicinal Plants. In a case study, the focus is laid on the in silico screening of bioactive phytochemicals from Rhododendron arboreum petals sourced from the Himalayan origin against Mycobacterium tuberculosis (Mtb) polyketide synthase-13, a critical enzyme for the synthesis of mycolic acid of the cell wall. Inhibition of this enzyme could be a potential target to inhibit the growth of Mtb, a leading cause of tuberculosis disease. The overall workflow is adoptable to study the potential of bioactive phytochemicals leading to drug discovery and development.
Related Journals
Current Clinical Pharmacology
Current Cancer Therapy Reviews
Current Nanomedicine
Current Psychopharmacology
Drug Delivery Letters
Letters in Drug Design & Discovery
Recent Advances in Anti-Infective Drug Discovery
Coronaviruses
Applied Drug Research, Clinical Trials and Regulatory Affairs
Anti-Infective Agents
Related Books
Medical Applications of Beta-Glucan
Postbiotics: Science, Technology and Applications
Evidence-Based Research in Ayurveda against COVID-19 in Compliance with Standardized Protocols and Practices
Pharmaceutical Chemistry and Production: An Introductory Textbook
Pharmaceuticals for Targeting Coronaviruses
New Findings from Natural Substances
Nanopharmacology and Nanotoxicology: Clinical Implications and Methods
Practice and Re-Emergence of Herbal Medicine
New Avenues in Drug Discovery and Bioactive Natural Products
Plant-derived Hepatoprotective Drugs